Florida physician Stephen Andrew Leedy, MD, has been accused of producing child sexual abuse materials and enticing minors to ...
U.S. pharmaceutical company pays $4.07 million to resolve allegations that it violated the False Claims Act (FCA) by failing to report research misconduct allegations in grant applications.
The United States accounted for the highest market size of MCI, approximately 52% of the total market size in 7MM in 2023, in comparison to the other major markets, i.e., EU4 countries (Germany, ...
According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...
Stressing the importance of integrity in taxpayer-funded biomedical research, the U.S. Department of Justice reported that Athira Pharma Inc. agreed to pay more than $4 million to resolve False Claims ...
Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it ...
Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False ...
A biopharmaceutical company, Athira Pharma, settled for $4.068 million over allegations of research misconduct.
Athira Pharma (ATHA) agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act by failing to report allegations of ...
The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...
Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies.
BOTHELL — A Bothell pharmaceutical company will pay more than $4 million to resolve allegations it used falsified research to ...